Molecular genetic analysis of mycobacterium tuberculosis in the pandemic COVID-19

Authors

  • Agigat Kadyrova НИИ Легочных Заболеваний, г. Баку, Азербайджан
  • Gunay Isazade НИИ Легочных Заболеваний, г. Баку, Азербайджан
  • Mehriban Sefeddinova НИИ Легочных Заболеваний, г. Баку, Азербайджан
  • Rafik Abuzarov НИИ Легочных Заболеваний, г. Баку, Азербайджан

DOI:

https://doi.org/10.52692/1857-0011.2021.1-69.06

Keywords:

tuberculosis, co-infection

Abstract

COVID-19 co-infection and tuberculosis are currently relevant in countries with a high tuberculosis burden. The article presents the results of a study of sensitivity to rifampicin in the context of the COVID-19 pandemic in both tuberculosis patients and patients with co-infection with COVID-19 and tuberculosis. Both in patients with tuberculosis and in patients with co-infection with Covid-19 and tuberculosis, sensitivity to rifampicin was observed more often than resistance. However, in co-infection with Covid-19 and tuberculosis, the percentage of resistance was much lower than in patients with tuberculosis

Author Biographies

Agigat Kadyrova, НИИ Легочных Заболеваний, г. Баку, Азербайджан

др. мед. наук., профессор

Gunay Isazade, НИИ Легочных Заболеваний, г. Баку, Азербайджан

врач-лаборант

Downloads

Published

2021-05-11

Issue

Vol. 69 No. 1 (2021): Medical Sciences

Section

Research Article

License

Copyright (c) 2021 Bulletin of the Academy of Sciences of Moldova. Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.